Barbara Kollmeyer

Barbara Kollmeyer is a senior reporter for MarketWatch, covering technology and innovation. She joined the Dow Jones network in 2013 after more than a decade at Reuters, where she covered topics ranging from biotechnology to banking. She has reported on some of the biggest stories in tech over the past few years, including Tesla's rise under Elon Musk, Bitcoin's volatile price swings and Nvidia's dominance in artificial intelligence chips. She also writes about how technology is transforming industries such as health care, transportation and retail. Kollmeyer has a master's degree in journalism from Columbia University and a bachelor's degree in biology from the Catholic University of America. She lives in New York with her husband and two children.

40%

The Daily's Verdict

This author has a poor reputation for journalistic standards and is not considered a reliable news source.

Bias

15%

Examples:

  • The author does not provide any evidence for the alleged drug use by Musk.
  • The author seems to be biased in favor of Elon Musk and his companies.
  • The author uses quotes from Musk without questioning their validity or context.

Conflicts of Interest

50%

Examples:

  • The author does not disclose any potential conflicts of interest in the article.
  • The author works for MarketWatch, a financial news site that may have conflicts of interest with the companies mentioned in the article.

Contradictions

100%

Examples:

Deceptions

50%

Examples:

Recent Articles

Elon Musk Denies Drug Use Allegations, Tesla Board Member Drops Re-Election Bid

Elon Musk Denies Drug Use Allegations, Tesla Board Member Drops Re-Election Bid

Broke On: Monday, 08 January 2024 Elon Musk, CEO of Tesla and SpaceX, has denied allegations that he uses drugs. Despite three years of random testing failing to find any trace of illegal substances in his system, concerns over drug use by executives at his companies have been raised.